People

rosenblum-276x303
Andrew Rosenblum, PhD
NDRI-USA - Investigator
Education
PhD, Psychology, Graduate Center, City University of New York
MA, Psychology, New School for Social Research
BA, Philosophy, Adelphi University
Research Interests
Opioid addiction, Medication assisted treatment, Chronic pain, Behavioral interventions, Technology based interventions
BIO
Andrew Rosenblum’s scientific contributions primarily include development and evaluation of psychosocial interventions (including eLearning and eTherapy applications) and prevalence surveys.  Many of his recent studies have focused on chronic pain, prescription opioid misuse, and medication assisted treatment such as methadone and buprenorphine.  He has published more than 100 peer-reviewed articles and has served as principal investigator on several NIDA funded studies.
Projects
Principal Investigator, Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts. Completed
Publications

Recent

Buckheit KA, Nolan J, Possemato K, Maisto S, Rosenblum A, Acosta M, Marsch LA (2022).
Insomnia predicts treatment engagement and symptom change: A secondary analysis of a web-based CBT intervention for veterans with PTSD symptoms and hazardous alcohol use
Translational Behavioral Medicine, 12 (1), ibab118. doi: 10.1093/tbm/ibab118. PMCID: PMC8764992.

Goldsamt LA, Rosenblum A, Appel P, Paris P, Nazia N (2021).
The impact of COVID-19 on opioid treatment programs in the United States
Drug and Alcohol Dependence, 228, 109049. doi: 10.1016/j.drugalcdep.2021.109049. PMCID: PMC8461004.

Xie H, Guarino H, Moore SK, Acosta M, Budney AJ, Rosenblum A, Marsch LA, Fong C (2021).
Web-based cognitive behavior therapy for chronic pain patients with aberrant drug-related behavior: How did it work and for whom?
Journal of Behavioral Medicine, 44 (5), 704-714. doi: 10.1007/s10865-021-00219-9. PMCID: PMC8658745.

Matusow H, Rosenblum A, Fong C (2021).
Online medication assisted treatment education for court professionals: Need, opportunities and challenges
Substance Use and Misuse, 56 (10), 1439-1447. doi: 10.1080/10826084.2021.1936045.

Cleland CM, Bennett AS, Elliott L, Rosenblum A, Britton PC, Wolfson-Stofko B (2020).
Between- and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference
Drug and Alcohol Dependence, 206, 107734. doi: 10.1016/j.drugalcdep.2019.107734. PMCID: PMC6980716.


Notable

Rosenblum A, Marsch LA, Joseph H, Portenoy RK (2008).
Opioids and the treatment of chronic pain: Controversies, current status, and future directions
Experimental and Clinical Psychopharmacology, 16 (5), 405-416. doi: 10.1037/a0013628. PMCID: PMC2711509.

Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD (2007).
Prescription opioid abuse among enrollees into methadone maintenance treatment
Drug and Alcohol Dependence, 90 (1), 64-71. doi: 10.1016/j.drugalcdep.2007.02.012.

Magura S, Rosenblum A (2001).
Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored
Mount Sinai Journal of Medicine, 68 (1), 62-74. PubMed Abstract.

Dr. Rosenblum's Google Scholar Profile
Selected Press